A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause
Clinical trial NCT04003155 · COMPLETED
Trial details
- NCT number
- NCT04003155
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-11
- Primary completion
- 2020-10-29
- Enrollment
- 527
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.